200 related articles for article (PubMed ID: 18781173)
1. BLT2 is expressed in PanINs, IPMNs, pancreatic cancer and stimulates tumour cell proliferation.
Hennig R; Osman T; Esposito I; Giese N; Rao SM; Ding XZ; Tong WG; Büchler MW; Yokomizo T; Friess H; Adrian TE
Br J Cancer; 2008 Oct; 99(7):1064-73. PubMed ID: 18781173
[TBL] [Abstract][Full Text] [Related]
2. Leukotriene B4 induces EMT and vimentin expression in PANC-1 pancreatic cancer cells: Involvement of BLT2 via ERK2 activation.
Kim YR; Park MK; Kang GJ; Kim HJ; Kim EJ; Byun HJ; Lee MY; Lee CH
Prostaglandins Leukot Essent Fatty Acids; 2016 Dec; 115():67-76. PubMed ID: 27914516
[TBL] [Abstract][Full Text] [Related]
3. Novel involvement of leukotriene B₄ receptor 2 through ERK activation by PP2A down-regulation in leukotriene B₄-induced keratin phosphorylation and reorganization of pancreatic cancer cells.
Park MK; Park Y; Shim J; Lee HJ; Kim S; Lee CH
Biochim Biophys Acta; 2012 Dec; 1823(12):2120-9. PubMed ID: 23017243
[TBL] [Abstract][Full Text] [Related]
4. Leukotriene B4 receptor antagonist LY293111 inhibits proliferation and induces apoptosis in human pancreatic cancer cells.
Tong WG; Ding XZ; Hennig R; Witt RC; Standop J; Pour PM; Adrian TE
Clin Cancer Res; 2002 Oct; 8(10):3232-42. PubMed ID: 12374694
[TBL] [Abstract][Full Text] [Related]
5. Role of the low-affinity leukotriene B4 receptor BLT2 in VEGF-induced angiogenesis.
Kim GY; Lee JW; Cho SH; Seo JM; Kim JH
Arterioscler Thromb Vasc Biol; 2009 Jun; 29(6):915-20. PubMed ID: 19286633
[TBL] [Abstract][Full Text] [Related]
6. Leukotriene B4 enhances the activity of nuclear factor-kappaB pathway through BLT1 and BLT2 receptors in atherosclerosis.
Sánchez-Galán E; Gómez-Hernández A; Vidal C; Martín-Ventura JL; Blanco-Colio LM; Muñoz-García B; Ortega L; Egido J; Tuñón J
Cardiovasc Res; 2009 Jan; 81(1):216-25. PubMed ID: 18852255
[TBL] [Abstract][Full Text] [Related]
7. An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
Hruban RH; Takaori K; Klimstra DS; Adsay NV; Albores-Saavedra J; Biankin AV; Biankin SA; Compton C; Fukushima N; Furukawa T; Goggins M; Kato Y; Klöppel G; Longnecker DS; Lüttges J; Maitra A; Offerhaus GJ; Shimizu M; Yonezawa S
Am J Surg Pathol; 2004 Aug; 28(8):977-87. PubMed ID: 15252303
[TBL] [Abstract][Full Text] [Related]
8. Mediatory role of BLT2 in the proliferation of KRAS mutant colorectal cancer cells.
Park J; Jang JH; Kim JH
Biochim Biophys Acta Mol Cell Res; 2019 Mar; 1866(3):329-336. PubMed ID: 30553812
[TBL] [Abstract][Full Text] [Related]
9. Leukotriene B
Jang JH; Wei JD; Kim M; Kim JY; Cho AE; Kim JH
Exp Mol Med; 2017 Nov; 49(11):e402. PubMed ID: 29170475
[TBL] [Abstract][Full Text] [Related]
10. Leukotriene B
Matsumoto Y; Matsuya Y; Nagai K; Amagase K; Saeki K; Matsumoto K; Yokomizo T; Kato S
J Pharmacol Exp Ther; 2020 Apr; 373(1):1-9. PubMed ID: 31941716
[TBL] [Abstract][Full Text] [Related]
11. Current topics on precursors to pancreatic cancer.
Takaori K; Hruban RH; Maitra A; Tanigawa N
Adv Med Sci; 2006; 51():23-30. PubMed ID: 17357272
[TBL] [Abstract][Full Text] [Related]
12. A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders.
Yokomizo T; Kato K; Terawaki K; Izumi T; Shimizu T
J Exp Med; 2000 Aug; 192(3):421-32. PubMed ID: 10934230
[TBL] [Abstract][Full Text] [Related]
13. Leukotriene B4 receptor 2 regulates the proliferation, migration, and barrier integrity of bronchial epithelial cells.
Liu M; Shen J; Yuan H; Chen F; Song H; Qin H; Li Y; Xu J; Ye Q; Li S; Saeki K; Yokomizo T
J Cell Physiol; 2018 Aug; 233(8):6117-6124. PubMed ID: 29323699
[TBL] [Abstract][Full Text] [Related]
14. Loss of Trefoil Factor 2 From Pancreatic Duct Glands Promotes Formation of Intraductal Papillary Mucinous Neoplasms in Mice.
Yamaguchi J; Mino-Kenudson M; Liss AS; Chowdhury S; Wang TC; Fernández-Del Castillo C; Lillemoe KD; Warshaw AL; Thayer SP
Gastroenterology; 2016 Dec; 151(6):1232-1244.e10. PubMed ID: 27523981
[TBL] [Abstract][Full Text] [Related]
15. Leukotriene B4 receptors BLT1 and BLT2: expression and function in human and murine mast cells.
Lundeen KA; Sun B; Karlsson L; Fourie AM
J Immunol; 2006 Sep; 177(5):3439-47. PubMed ID: 16920986
[TBL] [Abstract][Full Text] [Related]
16. Up-regulation of BLT2 is critical for the survival of bladder cancer cells.
Seo JM; Cho KJ; Kim EY; Choi MH; Chung BC; Kim JH
Exp Mol Med; 2011 Mar; 43(3):129-37. PubMed ID: 21252614
[TBL] [Abstract][Full Text] [Related]
17. Differential ezrin and phosphorylated ezrin expression profiles between pancreatic intraepithelial neoplasia, intraductal papillary mucinous neoplasm, and invasive ductal carcinoma of the pancreas.
Oda Y; Aishima S; Morimatsu K; Hayashi A; Shindo K; Fujino M; Mizuuchi Y; Hattori M; Tanaka M; Oda Y
Hum Pathol; 2013 Aug; 44(8):1487-98. PubMed ID: 23465281
[TBL] [Abstract][Full Text] [Related]
18. BLT2 promotes the invasion and metastasis of aggressive bladder cancer cells through a reactive oxygen species-linked pathway.
Kim EY; Seo JM; Kim C; Lee JE; Lee KM; Kim JH
Free Radic Biol Med; 2010 Sep; 49(6):1072-81. PubMed ID: 20600831
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic down-regulation of CDKN1C/p57KIP2 in pancreatic ductal neoplasms identified by gene expression profiling.
Sato N; Matsubayashi H; Abe T; Fukushima N; Goggins M
Clin Cancer Res; 2005 Jul; 11(13):4681-8. PubMed ID: 16000561
[TBL] [Abstract][Full Text] [Related]
20. A leukotriene B4 receptor-2 is associated with paclitaxel resistance in MCF-7/DOX breast cancer cells.
Kim H; Park GS; Lee JE; Kim JH
Br J Cancer; 2013 Jul; 109(2):351-9. PubMed ID: 23799854
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
